{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:53:13Z","timestamp":1793242393987,"version":"4.5.0"},"reference-count":105,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Breast Disease"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>Cancer stem cells (CSCs) are a small population of cells within a tumor which perform stem cell like functions including self-renewal, differentiation and initiation. This narrative review aims to provide an overview of the role of CSCs in resistance to standard treatment and metastasis in breast cancer, potential treatment strategies including latest clinical trials, and the clinical implications for CSCs in the management of breast cancer. The most established breast CSC markers (CD44+\/CD24- and ALDH1) are most prevalent in basal-like cancers, the most aggressive subtype of breast cancer. The most implicated CSC pathways include Hedgehog, Notch, CXCR1, and Wnt. Previous phase I\/II trials targeting these pathways associated with breast CSCs have shown mixed results; no CSC-specific drug has reached phase III trial in breast cancer. To maximize the potential benefit of CSC-targeted therapy, it would be important to select or enrich patients with CSC markers or CSC-associated pathway activation. It would also be critical to develop combination strategies that overcome plasticity and\/or immune invasion, and preferentially destroy CSCs with limited impact on healthy stem cells. Overall, breast CSCs may have greater clinical implications but require further research and development to realize their full clinical potential.<\/jats:p>","DOI":"10.1177\/15581551261469637","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:51:39Z","timestamp":1783785099000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical implications of breast cancer stem cells: A review"],"prefix":"10.1177","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3676-9059","authenticated-orcid":false,"given":"Wesley Oliver","family":"Wu","sequence":"first","affiliation":[{"name":"Upper Canada College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00758-0"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00288-6"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2824"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2018.11.006"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01851-y"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02360-2"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-023-10529-x"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.01.159"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2256"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02968135"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004764"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v7.i1.27"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8010008"},{"key":"e_1_3_5_17_2","first-page":"24032555","article-title":"The significance of cancer stem cells and epithelial-mesenchymal transition in metastasis and anti-cancer therapy","volume":"24","author":"Liang L","year":"2023","unstructured":"Liang L, Kaufmann AM. The significance of cancer stem cells and epithelial-mesenchymal transition in metastasis and anti-cancer therapy. Int J Mol Sci 2023; 24: 24032555. 2023\/02\/12. https:\/\/doi.org\/10.3390\/ijms24032555","journal-title":"Int J Mol Sci"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-04297-y"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2013.11.009"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/biology15030265"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00304"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2011.12.001"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqaf217"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.3109\/09553002.2014.892227"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1681"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109979"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1619597"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.10"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3730-2_5"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2011.090456"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2007.08.014"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.105"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-3326"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.1540"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2021.10.013"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-020-00895-5"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13727"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01389-8"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.381970"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05817-w"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0517"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05220-6"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39397"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2748"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1243-8"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06367-5"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.1094"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.4010"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-018-0060-z"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2010.10.015"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09851"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2008.00430.x"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011060614"},{"key":"e_1_3_5_54_2","first-page":"2147","article-title":"The hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-\/low subpopulation and the side population of breast cancer cells","volume":"29","author":"Tanaka H","year":"2009","unstructured":"Tanaka H, Nakamura M, Kameda C, et al. The hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-\/low subpopulation and the side population of breast cancer cells. Anticancer Res 2009; 29: 2147\u20132157. 2009\/06\/17.","journal-title":"Anticancer Res"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22225"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20140592"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.5856"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2948-z"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2219"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0054"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00410-y"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98098"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501675"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2015.03.012"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0457"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76611"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1308953111"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18860-4"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.06.2064"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1225"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2075-8"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0412-0"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049029"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.4.2341"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24028"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01068-6"},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6234"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.689286"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2741"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.319"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1007725107"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008011"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1159\/000098207"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3337"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067811"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-014-0408-8"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep12465"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4135"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606599104"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.111555"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.3390\/life15020228"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.61"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.02.027"},{"key":"e_1_3_5_94_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01905-7"},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.03.009"},{"key":"e_1_3_5_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.08.050"},{"key":"e_1_3_5_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.101"},{"key":"e_1_3_5_98_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1006429"},{"key":"e_1_3_5_99_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246209"},{"key":"e_1_3_5_100_2","first-page":"339","article-title":"Stat3\/Oct-4\/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066","volume":"53","author":"Cheng CC","year":"2018","unstructured":"Cheng CC, Shi LH, Wang XJ, et al. Stat3\/Oct-4\/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066. Int J Oncol 2018; 53: 339\u2013348. 2018\/05\/12. https:\/\/doi.org\/10.3892\/ijo.2018.4399","journal-title":"Int J Oncol"},{"key":"e_1_3_5_101_2","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32801403f4"},{"key":"e_1_3_5_102_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00824-1"},{"key":"e_1_3_5_103_2","article-title":"Targeting cancer stem cells with NEOadjuvant DOXYcycline in patients with early estrogen receptor positive\/human epidermal growth factor receptor 2-negative breast cancer. A prospective, multicenter, single arm","author":"NEODOXy","unstructured":"NEODOXy. Targeting cancer stem cells with NEOadjuvant DOXYcycline in patients with early estrogen receptor positive\/human epidermal growth factor receptor 2-negative breast cancer. A prospective, multicenter, single arm. Open Label Phase II Trial. https:\/\/clinicaltrials.gov\/study\/NCT06452394","journal-title":"Open Label Phase II Trial"},{"key":"e_1_3_5_104_2","unstructured":"A phase II trial of the immunogenicity of a DNA plasmid based vaccine (STEMVAC) encoding Th1 selective epitopes from five antigens associated with breast cancer stem cells (MDM2 YB1 SOX2 CDC25B CD105) in participants with early stage triple negative breast cancer. https:\/\/clinicaltrials.gov\/study\/NCT05455658"},{"key":"e_1_3_5_105_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00411-024-01102-2"},{"key":"e_1_3_5_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2021.02.006"}],"container-title":["Breast Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15581551261469637","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15581551261469637","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15581551261469637","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:32:47Z","timestamp":1784039567000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15581551261469637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":105,"alternative-id":["10.1177\/15581551261469637"],"URL":"https:\/\/doi.org\/10.1177\/15581551261469637","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"article-number":"15581551261469637"}}